IOL Chemicals and Pharmaceuticals Ltd (IOLCP):企業の財務・戦略的SWOT分析

◆英語タイトル:IOL Chemicals and Pharmaceuticals Ltd (IOLCP) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C5219
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:33
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:化学
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

IOL Chemicals and Pharmaceuticals Ltd (IOLCP) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

IOL Chemicals and Pharmaceuticals Ltd (IOLCP) is an India-based manufacturer and supplier of organic chemicals. The company offers an extensive range of specialty chemicals and bulk drugs. The specialty chemical products that the company offers include ethyl acetate, iso butyl benzene (IBB), mono chloro acetic acid (MCA) and acetyl chloride. It also manufactures numerous active pharmaceutical ingredients such as metformin hydrochloride, lamotrigine, fenofibrate, clopidogrel bi sulphate and Ibuprofen. IOLCP caters to textiles, pharmaceutical, packaging food processing, pesticides and paint industries. The company operates its manufacturing facilities in Barnala, Punjab. Geographically, the company serves markets such as India, Brazil, Belgium, Thailand, Indonesia, Spain, Syria, Egypt, South Africa and other countries. IOLCP is headquartered in Punjab, India.

IOL Chemicals and Pharmaceuticals Ltd Key Recent Developments

Aug 18,2017: IOL chemicals and pharmaceuticals Announced Financial Results For Quarter Ended June 30, 2017

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Section 1 – About the Company 5
IOL Chemicals and Pharmaceuticals Ltd – Key Facts 5
IOL Chemicals and Pharmaceuticals Ltd – Key Employees 6
IOL Chemicals and Pharmaceuticals Ltd – Key Employee Biographies 7
IOL Chemicals and Pharmaceuticals Ltd – Major Products and Services 8
IOL Chemicals and Pharmaceuticals Ltd – History 9
IOL Chemicals and Pharmaceuticals Ltd – Company Statement 10
IOL Chemicals and Pharmaceuticals Ltd – Locations And Subsidiaries 11
Head Office 11
Section 2 – Company Analysis 12
Company Overview 12
IOL Chemicals and Pharmaceuticals Ltd – Business Description 13
Business Segment: Bulk Drugs 13
Overview 13
Performance 13
Business Segment: Specialty Industrial Chemicals 13
Overview 13
Performance 13
Geographical Segment: Domestic Sales 13
Performance 13
Geographical Segment: Export Sales 14
Performance 14
IOL Chemicals and Pharmaceuticals Ltd – Corporate Strategy 15
IOL Chemicals and Pharmaceuticals Ltd – SWOT Analysis 16
SWOT Analysis – Overview 16
IOL Chemicals and Pharmaceuticals Ltd – Strengths 16
IOL Chemicals and Pharmaceuticals Ltd – Weaknesses 17
IOL Chemicals and Pharmaceuticals Ltd – Opportunities 18
IOL Chemicals and Pharmaceuticals Ltd – Threats 19
IOL Chemicals and Pharmaceuticals Ltd – Key Competitors 20
Section 3 – Company Financial Ratios 21
Financial Ratios – Capital Market Ratios 21
Financial Ratios – Annual Ratios 22
Performance Chart 25
Financial Performance 25
Financial Ratios – Interim Ratios 26
Financial Ratios – Ratio Charts 27
Section 4 – Company’s Recent Developments 28
Aug 18, 2017: IOL chemicals and pharmaceuticals Announced Financial Results For Quarter Ended June 30, 2017 28
Section 5 – Appendix 29
Methodology 29
Ratio Definitions 29
About GlobalData 33
Contact Us 33
Disclaimer 33

List of Tables
IOL Chemicals and Pharmaceuticals Ltd, Key Facts 5
IOL Chemicals and Pharmaceuticals Ltd, Key Employees 6
IOL Chemicals and Pharmaceuticals Ltd, Key Employee Biographies 7
IOL Chemicals and Pharmaceuticals Ltd, Major Products and Services 8
IOL Chemicals and Pharmaceuticals Ltd, History 9
IOL Chemicals and Pharmaceuticals Ltd, Key Competitors 20
IOL Chemicals and Pharmaceuticals Ltd, Ratios based on current share price 21
IOL Chemicals and Pharmaceuticals Ltd, Annual Ratios 22
IOL Chemicals and Pharmaceuticals Ltd, Annual Ratios (Cont...1) 23
IOL Chemicals and Pharmaceuticals Ltd, Annual Ratios (Cont...2) 24
IOL Chemicals and Pharmaceuticals Ltd, Interim Ratios 26
Currency Codes 29
Capital Market Ratios 29
Equity Ratios 30
Profitability Ratios 30
Cost Ratios 31
Liquidity Ratios 31
Leverage Ratios 32
Efficiency Ratios 32

List of Figures
IOL Chemicals and Pharmaceuticals Ltd, Performance Chart (2014 - 2018) 25
IOL Chemicals and Pharmaceuticals Ltd, Ratio Charts 27

★海外企業調査レポート[IOL Chemicals and Pharmaceuticals Ltd (IOLCP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Daqo New Energy Corp (DQ)-エネルギー分野:企業M&A・提携分析
    Summary Daqo New Energy Corp (Daqo Cayman) is a manufacturer of polysilicon and solar wafers. Through tolling agreements, the company also offers wafer original equipment manufacturer (OEM) services to external customers. It sells its products to solar cell and solar module manufacturers. Daqo Cayma …
  • Trinidad Drilling Ltd (TDG):企業の財務・戦略的SWOT分析
    Summary Trinidad Drilling Ltd (Trinidad Drilling) is an oil and gas company that offers drilling services. The company’s services include land and barge drilling, coring and presetting, well servicing, rig design and management, rig fleet management, and technical support services. Its in-house manu …
  • Micro Labs Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Micro Labs Ltd (Micro Labs) is a healthcare service organization which conducts research and development of bio equivalent generics. The organization’s business segments include formulations and active pharmaceutical ingredients. Its products include acetamide, allercet, amiodar, amlong, aml …
  • Burnet Institute:製薬・医療:M&Aディール及び事業提携情報
    Summary Burnet Institute is a non-profit and independent organization that improves health of poor and vulnerable communities through research, education and public health. The institute offers solutions to major health issues through development and discovery of novel vaccines, diagnostic tests and …
  • Asuragen Inc:医療機器:M&Aディール及び事業提携情報
    Summary Asuragen Inc (Asuragen) is an oncology molecular diagnostic company that provides laboratory medicine solutions. The company offers products such as amplidex, quantidex, and custom reagents. It provides custom and companion diagnostic services, which include commercialization, product approv …
  • Nanomerics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanomerics Ltd (Nanomerics) is a healthcare solution provider that develops drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. The company offers products such as METDoloron, METSporine, METAmphizon, METEnkalon, MET undisclosed, MET ocular undiscl, ocular und …
  • Group 1 Automotive, Inc.:企業の戦略・SWOT・財務情報
    Group 1 Automotive, Inc. - Strategy, SWOT and Corporate Finance Report Summary Group 1 Automotive, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • BioMedomics Inc:製品パイプライン分析
    Summary BioMedomics Inc (BioMedomics) is a point-of-care diagnostics company that develops immunologically-based disease-specific tests and advanced highly sensitive quantitative platforms. The company provides technologies such as time-resolved lateral flow immunoassay and nanotube based POC platfo …
  • Purdue Pharma LP-製薬・医療分野:企業M&A・提携分析
    Summary Purdue Pharma LP (Purdue) is a privately held, US-based pharmaceutical company which develops pharmacologic therapies for the treatment and management of pain. The company undertakes the research, development, manufacture and marketing of prescription medicines and over-the-counter (OTC) med …
  • Neurimmune Holding AG:製薬・医療:M&Aディール及び事業提携情報
    Summary Neurimmune Holding AG (Neurimmune), formerly Neurimmune Therapeutics AG is a biopharmaceutical company that develops immunotherapeutics for human diseases. The company’s pipeline products include human-derived monoclonal antibodies developed for the treatment and prevention of human neurodeg …
  • Boralex Inc (BLX)-エネルギー分野:企業M&A・提携分析
    Summary Boralex Inc. (Boralex) is a renewable energy company that develops, constructs, and operates power plants. It produces electricity from wind, solar, hydro, natural gas, and wood residue sources; and sells that energy through long-term contracts. Boralex sources wood residues such as bark, wo …
  • The Arab Assurers Insurance Co.:企業の戦略・SWOT・財務情報
    The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report Summary The Arab Assurers Insurance Co. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • General Electric Co (GE)-エネルギー分野:企業M&A・提携分析
    Summary General Electric Company (GE) is a digital industrial company. It offers a range of industrial, infrastructure and financial services globally. The company offers a range of products and services from aircraft engines, power generation and oil and gas production equipment to medical imaging, …
  • Army and Air Force Exchange Service:企業の戦略・SWOT・財務情報
    Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report Summary Army and Air Force Exchange Service - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • JD Sports Fashion Plc:企業のM&A・事業提携・投資動向
    JD Sports Fashion Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's JD Sports Fashion Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • James Cropper PLC (CRPR):企業の財務・戦略的SWOT分析
    James Cropper PLC (CRPR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • MBDA Holdings SAS:企業の戦略・SWOT・財務情報
    MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report Summary MBDA Holdings SAS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Maxim Integrated Products, Inc.:企業の戦略・SWOT・財務分析
    Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Maxim Integrated Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • BDI – BioEnergy International AG:企業の戦略的SWOT分析
    BDI - BioEnergy International AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Serco Group plc (SRP):企業の財務・戦略的SWOT分析
    Serco Group plc (SRP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆